JPRN-jRCT2080222040未知2 期
Phase II/III clinical trial of L-105 in patients with hepatic encephalopathy
适应症
试验速览
- 阶段
- 2 期
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 74age old（—）
- 性别
- All
入选标准
- •Diagnosed as hepatic cirrhosis. In addition, patients having portal-systemic shunt without hepatic cirrhosis are eligible.
- •-Hyperammonemia
- •-Grade I or II mental state of H.E. (Classification by Inuyama Symposium)
排除标准
- •-A concurrent mental illness
- •-Acute hepatitis or in the acute exacerbation phase of chronic hepatitis
- •-Concurrent hepatocellular carcinoma. However, patients, who were locally treated with hepatectomy, radio-frequency ablation (RFA), transcatheter hepatic arterial embolization (TAE), or percutaneous ethanol injection therapy (PEIT) 4 weeks prior to the start of study medication, are eligible.
- •-Planning to receive new treatment for hepatocellular carcinoma during the study period
- •-Likely to undergo liver transplant within 6 months after enrollment
研究者
相似试验
未知
3 期
Phase III clinical trial of L-105 in patients with hepatic encephalopathyH.E.JPRN-jRCT2080222041ASKA Pharmaceutical Co., Ltd.180
已完成
2 期
Phase II/III clinical trial of L-105 in pediatric patients with hepatic encephalopathyHepatic encephalopathyJPRN-jRCT2080224978ASKA Pharmaceutical Co., Ltd.20
未知
2 期
A phase II study of NK105 for patients with previously treated advanced or recurrent gastric cancer.Gastric cancerJPRN-jRCT2080220741ippon Kayaku Co., Ltd.
招募中
1 期
Study of LY3537982 in Cancer Patients with a Specific Genetic Mutation (KRAS G12C)SCLCCRCEndometrial NeoplasmsOvarian NeoplasmsPancreatic NeoplasmsBiliary Tract NeoplasmsFrontline, 1L, First LineJPRN-jRCT2031210265Masaki Takeshi80
进行中（未招募）
1 期
A trial to evaluate MLN0264 for the treatment of pancreatic tumors which have a protein called Guanylyl Cyclase C (GCC) present, in patients that have been treated previously and in whom the cancer is advanced or has spread.Metastatic or Advanced Adenocarcinoma of the Pancreas Expressing Guanylyl Cyclase C (GCC)MedDRA version: 17.0Level: LLTClassification code 10033599Term: Pancreatic adenocarcinoma metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 17.0Level: LLTClassification code 10051971Term: Pancreatic adenocarcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 17.0Level: PTClassification code 10052747Term: Adenocarcinoma pancreasSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-000805-11-ITMillennium Pharmaceuticals, Inc.43